Suppr超能文献

内镜辅助乳房重建中假体感染的微创与创新处理。

Minimally Invasive and Innovative Management of Prosthesis Infections in Endoscopic-Assisted Breast Reconstruction.

机构信息

Department of General Surgery, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu, 610041, China.

Breast Center, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Aesthetic Plast Surg. 2024 Feb;48(3):266-272. doi: 10.1007/s00266-023-03525-6. Epub 2023 Aug 21.

Abstract

BACKGROUND

Implant infection continues to be the most common complication of breast reconstruction, and it can lead to serious consequences of implant loss. Recently, endoscopic-assisted nipple-sparing mastectomy with direct-to-implant breast reconstruction is being performed more frequently, with similar prosthetic infection incidence compared to conventional techniques. But there is little information published in the literature on the management of periprosthetic infection in endoscopic-assisted breast reconstruction.

METHODS

A retrospective review was performed of patients who underwent endoscope-assisted breast reconstruction and developed periprosthetic infection between January 2020 and December 2022. Prosthesis infection was defined as any case where antibiotics were given, beyond the surgeon's standard perioperative period, in response to clinical signs such as swelling, pain, erythema, increased temperature, fever, etc. We summarized our clinical approach and treatment protocol for periprosthetic infection patients. Collected data include preoperative basic information, surgical details, postoperative data, and outcomes.

RESULTS

A total of 580 patients (713 reconstructions) underwent endoscopic-assisted immediate breast reconstruction. There were 58 patients developed periprosthetic infection, 14 of whom had bilateral prosthesis reconstruction with unilateral prosthesis infection. The incidence of infection was 10.0%. Average follow-up was 17.3 ± 8.9 months (range = 2-37 months). Of the 58 patients, 53 (91.4%) patients successful salvaged implant and 5(8.6%) patients removed prosthesis. During follow-up, Baker III capsular contracture occurred in 2 patients (3.8%) who had radiotherapy.

CONCLUSION

Our management of prosthesis infections in endoscopic-assisted breast reconstruction is easy, minimally invasive, and inexpensive. This method can be repeated if the implant infection does not improve after the first drainage. What's more, our data suggest that our prosthesis salvage of periprosthetic infection is effective.

LEVEL OF EVIDENCE IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

摘要

背景

植入物感染仍然是乳房重建最常见的并发症,可导致严重的植入物丢失后果。最近,内镜辅助保留乳头的乳房切除术联合直接植入物乳房重建的应用越来越多,其假体感染发生率与传统技术相似。但是,关于内镜辅助乳房重建中假体周围感染的管理,文献中发表的信息很少。

方法

对 2020 年 1 月至 2022 年 12 月期间行内镜辅助乳房重建并发生假体周围感染的患者进行回顾性研究。假体感染的定义为任何情况下,在外科医生的标准围手术期之外,由于肿胀、疼痛、红斑、体温升高、发热等临床症状,给予抗生素治疗。我们总结了假体周围感染患者的临床处理方法和治疗方案。收集的数据包括术前基本信息、手术细节、术后资料和结果。

结果

共 580 例患者(713 例重建)行内镜辅助即刻乳房重建。58 例患者发生假体周围感染,其中 14 例双侧假体重建,单侧假体感染。感染发生率为 10.0%。平均随访 17.3±8.9 个月(范围 2-37 个月)。58 例患者中,53 例(91.4%)成功保留了植入物,5 例(8.6%)患者移除了假体。随访期间,2 例(3.8%)接受过放疗的患者发生 Baker III 级包膜挛缩。

结论

我们对内镜辅助乳房重建中假体感染的处理方法简单、微创且经济。如果第一次引流后感染仍未改善,可以重复该方法。此外,我们的数据表明,我们对假体周围感染的假体保留是有效的。

证据等级 IV:本刊要求作者为每篇文章指定一个证据等级。有关这些循证医学等级的完整描述,请参考目录或在线作者指南 www.springer.com/00266

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验